1. Home
  2. STRT vs RCKT Comparison

STRT vs RCKT Comparison

Compare STRT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STRATTEC SECURITY CORPORATION

STRT

STRATTEC SECURITY CORPORATION

HOLD

Current Price

$60.35

Market Cap

241.4M

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$2.27

Market Cap

239.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRT
RCKT
Founded
1908
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
241.4M
239.3M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
STRT
RCKT
Price
$60.35
$2.27
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
★ $8.58
AVG Volume (30 Days)
45.9K
★ 2.2M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
9.17
★ 26.37
EPS
★ 5.00
0.66
Revenue
★ $439,195,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.24
$915.60
P/E Ratio
$12.13
★ $3.50
Revenue Growth
★ 5.24
N/A
52 Week Low
$57.01
$2.17
52 Week High
$93.00
$5.45

Technical Indicators

Market Signals
Indicator
STRT
RCKT
Relative Strength Index (RSI) 31.54 37.77
Support Level $57.01 N/A
Resistance Level $83.87 $3.70
Average True Range (ATR) 1.74 0.18
MACD 0.07 0.02
Stochastic Oscillator 18.55 18.70

Price Performance

Historical Comparison
STRT
RCKT

About STRT STRATTEC SECURITY CORPORATION

Strattec Security Corp designs automotive access company that designs and delivers safe, secure, and engineered access solutions for the automotive and mobility markets. Built on generations of access and security engineering expertise, partner closely with OEMs to create differentiated, system level access experiences for end consumers. Its product portfolio spans the access journey from Permission, enabling secure vehicle entry through advanced mechanical and electronic systems; to Motion, delivering effortless, reliable powered access that enhances everyday usability; and through to Hold, providing precision engineered latching solutions.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: